Early Origins of Adult Health Research Group, Health and Biomedical Innovation, University of South Australia, Adelaide, SA, Australia.
Molecular and Evolutionary Physiology of the Lung Laboratory, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Pediatr Res. 2022 Mar;91(4):828-838. doi: 10.1038/s41390-021-01489-4. Epub 2021 Apr 15.
In the fetus, the appropriate balance of prooxidants and antioxidants is essential to negate the detrimental effects of oxidative stress on lung maturation. Antioxidants improve respiratory function in postnatal life and adulthood. However, the outcomes and biological mechanisms of antioxidant action in the fetal lung are unknown.
We investigated the effect of maternal daily vitamin C treatment (200 mg/kg, intravenously) for a month in late gestation (105-138 days gestation, term ~145 days) on molecular regulation of fetal lung maturation in sheep. Expression of genes and proteins regulating lung development was quantified in fetal lung tissue. The number of surfactant-producing cells was determined by immunohistochemistry.
Maternal vitamin C treatment increased fetal lung gene expression of the antioxidant enzyme SOD-1, hypoxia signaling genes (HIF-2α, HIF-3α, ADM, and EGLN-3), genes regulating sodium movement (SCNN1-A, SCNN1-B, ATP1-A1, and ATP1-B1), surfactant maturation (SFTP-B and ABCA3), and airway remodeling (ELN). There was no effect of maternal vitamin C treatment on the expression of protein markers evaluated or on the number of surfactant protein-producing cells in fetal lung tissue.
Maternal vitamin C treatment in the last third of pregnancy in sheep acts at the molecular level to increase the expression of genes that are important for fetal lung maturation in a healthy pregnancy.
Maternal daily vitamin C treatment for a month in late gestation in sheep increases the expression of gene-regulating pathways that are essential for normal fetal lung development. Following late gestation vitamin C exposure in a healthy pregnancy, an increase in lung gene but not protein expression may act as a mechanism to aid in the preparation for exposure to the air-breathing environment after birth. In the future, the availability/development of compounds with greater antioxidant properties than vitamin C or more specific targets at the site of oxidative stress in vivo may translate clinically to improve respiratory outcomes in complicated pregnancies at birth.
在胎儿期,合适的氧化剂和抗氧化剂平衡对于抵消氧化应激对肺成熟的有害影响至关重要。抗氧化剂可改善出生后和成年期的呼吸功能。然而,抗氧化剂在胎儿肺中的作用的结果和生物学机制尚不清楚。
我们研究了在妊娠晚期(105-138 天妊娠,足月约 145 天)期间每天静脉注射 200mg/kg 维生素 C 对绵羊胎儿肺成熟的分子调节作用。用胎儿肺组织定量检测调节肺发育的基因和蛋白质的表达。通过免疫组织化学法确定产生表面活性剂的细胞数量。
母体维生素 C 处理增加了胎儿肺抗氧化酶 SOD-1、缺氧信号基因(HIF-2α、HIF-3α、ADM 和 EGLN-3)、调节钠运动的基因(SCNN1-A、SCNN1-B、ATP1-A1 和 ATP1-B1)、表面活性剂成熟(SFTP-B 和 ABCA3)和气道重塑(ELN)的基因表达。母体维生素 C 处理对胎儿肺组织中评估的蛋白质标志物的表达或表面活性蛋白产生细胞的数量没有影响。
在绵羊妊娠的最后三分之一期间进行母体维生素 C 处理,可在分子水平上增加对健康妊娠中胎儿肺成熟很重要的基因表达。
在绵羊妊娠晚期每天进行一个月的母体维生素 C 处理可增加调节正常胎儿肺发育的基因表达途径。在健康妊娠中晚期暴露于维生素 C 后,肺基因表达增加而不是蛋白质表达增加可能是一种机制,有助于为出生后暴露于空气呼吸环境做准备。将来,具有比维生素 C 更大的抗氧化特性或在体内氧化应激部位更具特异性的化合物的可用性/发展,可能会在临床上转化为改善出生时复杂妊娠的呼吸结局。